Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 72.4B | 70.3B | 74.9B | 76.5B |
Cost of revenue | 60.6B | 63.5B | 63.2B | 61.6B |
Gross profit | 11.9B | 6.8B | 11.8B | 14.9B |
Operating expense | ||||
Research & development | — | 225.4M | 229.5M | 187.9M |
Selling general and admin | 7.0B | -560.7M | 2.3B | 2.9B |
Other operating expenses | — | — | — | — |
Operating income | 11.9B | -1.8B | 4.9B | 7.7B |
Non operating interest income | ||||
Income | — | 765.8M | 661.4M | 593.0M |
Expense | — | 56.1M | 58.7M | 59.6M |
Other income expense | — | — | — | — |
Pretax income | 5.0B | 4.4B | 3.1B | 10.3B |
Tax provision | 995.4M | -3.4M | 761.5M | 2.6B |
Net income | 4.1B | 4.4B | 2.4B | 7.7B |
Basic EPS | 393.2 | — | 229 | 748 |
Diluted EPS | 393.2 | — | 229 | 748 |
Basic average shares | — | — | 10.3M | 10.3M |
Diluted average shares | — | — | 10.3M | 10.3M |
EBITDA | 11.9B | 9.1B | 7.7B | 15.0B |
Net income from continuing op. | — | 4.4B | 2.4B | 7.7B |
Minority interests | -16.2M | -76.9M | -26.0M | -49.9M |
Preferred stock dividends | — | — | — | — |